Ischemic Optic Neuropathy Decompression Trial (IONDT)

Update Item Information
Identifier 19930209_nanos_clinicaltrialsympos_04
Title Ischemic Optic Neuropathy Decompression Trial (IONDT)
Creator Steven E. Feldon, MD, MBA
Affiliation Flaum Eye Institute / University of Rochester Medical Center, Rochester, NY
Subject Ischemic Optic Neuropathy Decompression Trial; Ischemic Optic Neuropathy Natural History; NAION Pathophysiology; Optic Nerve Decompression; Randomized Trial
Description Non-arteritic ischemic optic neuropathy (NAION), the most common cause of acute optic nerve disease in the elderly causes permanent and severe visual loss through decreased central visual acuity, peripheral visual field loss, or both. No proven treatment currently exists to reverse or arrest this loss. NAION strikes both eyes in up to 40% of affected patients. 4 To date, incidence and prevalence data have not been available; however, data collected by Dr. Kelman from a sample of U.S. neuro-ophthalmologists has suggested that 6,100 ner cases are seen each year in the U.S., or an annual incidence of 2.44 per 100,000.
Date 1993-02-09
Language eng
Format application/pdf
Type Text
Source 1993 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 1993: Clinical Trials Symposium
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 1993. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s65j0nw3
Setname ehsl_novel_nam
ID 182876
Reference URL https://collections.lib.utah.edu/ark:/87278/s65j0nw3
Back to Search Results